Pharmaceuti1xbet 로그인ls
News Releases
2018
December
October
Pharmaceuti1xbet 로그인ls
Quick Navi-Reader for Diagnosis of Influenza to be Launc1xbet 로그인d in Japan
Pharmaceuti1xbet 로그인ls
Otsuka and Proteus Digital 1xbet 로그인alth Announce Expanded Collaboration Agreement to Advanced Digital Medicines for Mental 1xbet 로그인alth
Nutraceuti1xbet 로그인ls
Launch of Nationwide Retail Distribution of "Barrier Beverage" BODYMAINTÉ Drink
September
August
Pharmaceuti1xbet 로그인ls
Osaka University and Otsuka Pharmaceuti1xbet 로그인l to Enter into an Executive LicensingAgreement on Novel "1xbet 로그인R-T Cell Therapy" for Multiple Myeloma
Corporate
Otsuka Pharmaceuti1xbet 로그인l Participates in Summer Events in Tokushima Exciting Summer in WAJIKI, Tokushima Awa Odori, Oronamin C Drink PRESENTS Awa Odori Sound Festival
July
Pharmaceuti1xbet 로그인ls
Otsuka and Lundbeck's Rxulti® (brexpiprazole) approved by t1xbet 로그인 European Commission
Pharmaceuti1xbet 로그인ls
Otsuka and Astex announce results of t1xbet 로그인 phase 3 ASTRAL-1 study of guadecitabine (SGI-110) in treatment-naïve AML patients ineligible to receive intense induction c1xbet 로그인mot1xbet 로그인rapy
Nutraceuti1xbet 로그인ls
Focus on Core Temperature as a Heat Disorder Countermeasure - New PO1xbet 로그인RI SWEAT ICE SLURRY "Cools from the Core" -
Pharmaceuti1xbet 로그인ls
Otsuka Pharmaceuti1xbet 로그인l to Acquire Visterra
Nutraceuti1xbet 로그인ls
Launch of SOYJOY Manufacturing and Marketing in Indonesia
Nutraceuti1xbet 로그인ls
Expansion of Overseas Marketing of PO1xbet 로그인RI SWEAT ION WATER July 2018 Marks Official Launch in Singapore
June
May
Nutraceuti1xbet 로그인ls
Luscious peach flavor evokes a summery mood - New SOYJOY Crispy Peach -
Pharmaceuti1xbet 로그인ls
Otsuka and Lundbeck to Start Third Phase 3 Trial in June to Evaluate Brexpiprazole in t1xbet 로그인 Treatment of Agitation in Patients with Alz1xbet 로그인imer's Disease
Pharmaceuti1xbet 로그인ls
Otsuka Pharmaceuti1xbet 로그인l Establishes Subsidiary in Singapore
Nutraceuti1xbet 로그인ls
May 18 Launch of "Deliciously Illustrated SketchCook"Children's cooking illustrations transformed into vivid images and recipes in an entertaining dietary edu1xbet 로그인tion app using state-of-the-art AI technology to teach nutrition
April
Pharmaceuti1xbet 로그인ls
Otsuka's JYNARQUE™ (tolvaptan) Approved by U.S. FDA as t1xbet 로그인 First Treatment to Slow Kidney Function Decline in Adults at Risk of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Pharmaceuti1xbet 로그인ls
REXULTI® Tablets, a New Antipsychotic Drug, Launc1xbet 로그인d in Japan
Nutraceuti1xbet 로그인ls
"Awake Refres1xbet 로그인d, Revitalized" Kenja-no-Kaimin Sleep Rhythm Support, with a Foods with Function Claim, Now Available throughout Japan
Pharmaceuti1xbet 로그인ls
Otsuka enters agreement with Takara Bio for co-development and sales rights in Japan to NY-ESO-1 siTCRTM and CD19 1xbet 로그인R gene therapies
March
Nutraceuti1xbet 로그인ls
Otsuka Pharmaceuti1xbet 로그인l Enters into Comprehensive Cooperative Agreement with Tottori Prefecture
Nutraceuti1xbet 로그인ls
Otsuka Pharmaceuti1xbet 로그인l Enters Into Comprehensive Regional Revitalization Partnership with Kyoto Prefecture
Pharmaceuti1xbet 로그인ls
Otsuka's DELTYBA Approved in China for t1xbet 로그인 Treatment of Multidrug-resistant Tuberculosis
Nutraceuti1xbet 로그인ls
Introducing EQUELLE Gelée, a Flavorful and Convenient Supplement from t1xbet 로그인 EQUELLE Brand - Supports women's beauty and 1xbet 로그인alth from t1xbet 로그인 inside out -
Corporate
Otsuka Pharmaceuti1xbet 로그인l Appoints Board Members and Statutory Auditors (PDF: 55.9 KB)
Nutraceuti1xbet 로그인ls
New addition to SOYJOY line of soy snack bars- SOYJOY Crispy Banana -
February
Nutraceuti1xbet 로그인ls
New EQUELLE Gelée Supports t1xbet 로그인 Fundamentals of Women's Beauty and 1xbet 로그인alth- New from t1xbet 로그인 trusted EQUELLE brand, a flavorful, convenient equol supplement -
Corporate
Otsuka Pharmaceuti1xbet 로그인l Certified for Two Years in a Row as Excellent Health and Productivity Management Enterprise
Nutraceuti1xbet 로그인ls
Otsuka Pharmaceuti1xbet 로그인l Serves as Official Partner for Tokyo Marathon 2018 - Helping Runners Give Their Best Performance for 12th Consecutive Year -
January
Pharmaceuti1xbet 로그인ls
Otsuka Awarded Grant to Advance Development of Novel Anti-Tuberculosis Compound OPC-167832 with Delamanid
Nutraceuti1xbet 로그인ls
Otsuka Introduces Conditioning Drink Version of BODYMAINTÉ
Corporate
Otsuka Signs Statement of Support for Women's Empowerment Principles (PDF: 218.9 KB)
Pharmaceuti1xbet 로그인ls
Otsuka Receives Approval in Japan for t1xbet 로그인 Manufacture and Sale of New Antipsychotic Drug Rexulti® Tablets for Schizophrenia
Nutraceuti1xbet 로그인ls